Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging

Clinical trial NCT06276465 · RECRUITING

Trial details

NCT number: NCT06276465
Sponsor: UNICANCER
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Prostatic Cancer, Castration-Resistant

Start date: 2024-10-07
Primary completion: 2029-10-15
Enrollment: 336

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.